📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations. (2015)

First Author: Upton LM

Attributed to: MRC Centre for Outbreak Analysis and Modelling Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1128/aac.03942-14

PubMed Identifier: 25385107

Publication URI: http://europepmc.org/abstract/MED/25385107

Type: Journal Article/Review

Volume: 59

Parent Publication: Antimicrobial agents and chemotherapy

Issue: 1

ISSN: 0066-4804